Scientists discover reasons why targeted immuno-oncology drugs sometimes fail
from Ohio State University Wexner Medical Center via EurekAlert
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063